Design, Synthesis, and Structure−Activity Relationships of a Series of 3-[2-(1-Benzylpiperidin-4-yl)ethylamino]pyridazine Derivatives as Acetylcholinesterase Inhibitors-Reference-Cited by-同舟云学术

Design, Synthesis, and Structure−Activity Relationships of a Series of 3-[2-(1-Benzylpiperidin-4-yl)ethylamino]pyridazine Derivatives as Acetylcholinesterase Inhibitors

Published:2001-07-20 Issue:17 Volume:44 Page:2707-2718
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Contreras Jean-Marie¹,Parrot Isabelle¹,Sippl Wolfgang¹,Rival Yveline M.¹,Wermuth Camille G.¹

Affiliation:

1. Laboratoire de Pharmacochimie de la Communication Cellulaire, UMR 7081 du CNRS, Université Louis Pasteur, Faculté de Pharmacie, 74, route du Rhin, 67401 Illkirch Cedex, France, and Institut für Pharmazeutische Chemie, Heinrich-Heine-Universität, Düsseldorf, Universitätsstr. 1, D-40225 Düsseldorf, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm001088u

Reference48 articles.

1. Alzheimer Disease 1999

2. SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE

3. From Molecular Structure to Alzheimer Therapy

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Formal [4+2] combined ionic and radical approach of vinylogus enaminonitriles for highly substituted sulfonyl pyridazines;2024-09-03

2. N‐Benzyl piperidine Fragment in Drug Discovery;ChemMedChem;2024-08-23

3. Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma;Journal of Medicinal Chemistry;2024-01-11

4. Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations;Journal of Medicinal Chemistry;2022-12-16

5. Role of pyridazine analogs as acetylcholinesterase inhibitor: An approach for management of alzheimer's disease;EURASIAN CHEM COMMUN;2021